NCT01962363 - EPI-743 in Friedreich's Ataxia Point Mutations | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Friedreich's Ataxia

Interventions

DRUG

EPI-743

EPI-743 (alpha-tocotrienol quinone) is a small molecule therapeutic that was rationally designed to replete reduced glutathione through NQO1-catalyzed electron transfer from NADPH.

Trial Locations (1)

33612

University of South Florida, Tampa